Risk of cardiovascular outcomes in patients with type 2 diabetes after addition of SGLT2 inhibitors versus sulfonylureas to baseline GLP-1RA therapy
Personalized GLP-1 Therapy for Hypothyroidism Patients PlexusDx offers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan from licensed 503A compounding pharmacies, with dosing flexibility to match individual needs
Mood, Motivation, and Addictive Behaviors: Finally, GLP-1s seem to have meaningful effects on behaviorespecially in the areas of reward, motivation, and habit loops
Limited exceptions: Case-by-case PA review for certain FDA-approved non-weight-loss uses (e.g., Wegovy for CVD risk reduction or MASH , Zepbound for OSA ) and EPSDT for members under 21
Juno spied the newfound maelstrom, which is about as wide as Texas, on Nov